MedTrace Logo

Psychoeducational and Behavioral Strategies in Reducing Distress and Anxiety in Patients With Multiple Myeloma and Their Family Caregivers

NCT02129569 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-03-20

No results posted yet for this study

Summary

This pilot clinical trial studies how well psychoeducational and behavioral strategies work in reducing distress and anxiety in patients with multiple myeloma and their family caregivers. Education and walking programs, may be able to reduce distress and anxiety and improve the well-being and quality of life of patients with multiple myeloma and their family caregivers. Understanding how different forms of education and support can promote emotional wellness may help nurse researchers find ways to improve services provided to patients and family members during cancer treatment.

Conditions

Interventions

OTHER

Psychoeducational intervention

Receive information about strategies for cognitive self-management of distress

BEHAVIORAL

behavioral intervention

Receive individualized walking prescription and wear pedometer

OTHER

counseling intervention

Receive supplemental counseling support over the phone

OTHER

educational intervention

Receive NCI educational booklets and a link to the ACS website

OTHER

telephone-based intervention

Receive calls that are primarily social in nature

OTHER

questionnaire administration

Ancillary studies

OTHER

quality-of-life assessment

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Susan Mazanec · Case Comprehensive Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-11
Primary Completion
2015-04-11
Completion
2016-08-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02129569 on ClinicalTrials.gov